Management of lower extremity peripheral arterial disease
- PMID: 19008688
- PMCID: PMC2743684
- DOI: 10.1097/HCR.0b013e31818c3b96
Management of lower extremity peripheral arterial disease
Abstract
Peripheral arterial disease (PAD), a manifestation of systemic atherosclerosis, is a significant health problem. It manifests in lower extremities as intermittent claudication, limb ischemia, or gangrene and other locations as stroke, renal failure, or mesenteric ischemia. Fontaine and Rutherford classifications are the 2 commonly used classifications to stage the severity of PAD. The diagnostic tools include ankle-brachial index, a valuable tool in diagnosing lower extremity PAD, and a treadmill test. Other useful diagnostic tools include the San Diego Claudication Questionnaire to screen patients for symptoms and imaging modalities such as duplex scan, angiogram, computer tomographic angiogram, and magnetic resonance angiogram. Medical management of PAD involves comprehensive care, including risk factor modification of etiologies predisposing to atherosclerosis. These involve using antiplatelet therapy with aspirin or clopidogrel, controlling hypertension, managing hypercholesterolemia, and using vasodilators such as cilostazol. Exercise rehabilitation is an efficacious approach to improve intermittent claudication and should be recommended to each patient. Revascularization therapy is indicated for those who have critical limb ischemia or severe claudication not improved by medical management. Revascularization consists of endovascular techniques to open up the vessel and traditional bypass surgery to bypass the diseased segment. Recent published guidelines detailing recommendations on different treatment modalities in patients with PAD are described.
Similar articles
-
Peripheral artery disease: current insight into the disease and its diagnosis and management.Mayo Clin Proc. 2010 Jul;85(7):678-92. doi: 10.4065/mcp.2010.0133. Mayo Clin Proc. 2010. PMID: 20592174 Free PMC article.
-
Peripheral arterial disease in women.Maturitas. 2009 Dec 20;64(4):204-11. doi: 10.1016/j.maturitas.2009.10.001. Epub 2009 Oct 22. Maturitas. 2009. PMID: 19853389 Review.
-
Management of peripheral arterial disease of the lower extremities.Compr Ther. 2007 Winter;33(4):247-56. doi: 10.1007/s12019-007-8013-8. Compr Ther. 2007. PMID: 18025617 Review.
-
Management of peripheral arterial disease of the lower extremities in elderly patients.J Gerontol A Biol Sci Med Sci. 2004 Feb;59(2):172-7. doi: 10.1093/gerona/59.2.m172. J Gerontol A Biol Sci Med Sci. 2004. PMID: 14999033 Review.
-
Management of peripheral arterial disease and intermittent claudication.J Am Board Fam Pract. 2001 Nov-Dec;14(6):443-50. J Am Board Fam Pract. 2001. PMID: 11757887 Review.
Cited by
-
Retrospective Evaluation of the Effect of Lumbar Sympathetic Blockade on Pain Scores, Fontaine Classification, and Collateral Perfusion Status in Patients with Lower Extremity Peripheral Arterial Disease.Medicina (Kaunas). 2024 Apr 23;60(5):682. doi: 10.3390/medicina60050682. Medicina (Kaunas). 2024. PMID: 38792864 Free PMC article.
-
Targeting Mitochondrial Dynamics during Lower-Limb Ischemia Reperfusion in Young and Old Mice: Effect of Mitochondrial Fission Inhibitor-1 (mDivi-1).Int J Mol Sci. 2024 Apr 4;25(7):4025. doi: 10.3390/ijms25074025. Int J Mol Sci. 2024. PMID: 38612835 Free PMC article.
-
Cilostazol Effects after Lower Extremity Revascularization. Historical Background and Review of the Literature.Maedica (Bucur). 2023 Dec;18(4):665-671. doi: 10.26574/maedica.2023.18.4.665. Maedica (Bucur). 2023. PMID: 38348074 Free PMC article.
-
Understanding Gangrene in the Context of Peripheral Vascular Disease: Prevalence, Etiology, and Considerations for Amputation-Level Determination.Cureus. 2023 Nov 18;15(11):e49026. doi: 10.7759/cureus.49026. eCollection 2023 Nov. Cureus. 2023. PMID: 38116352 Free PMC article. Review.
-
Intensity-dependent effects of exercise therapy on walking performance and aerobic fitness in symptomatic patients with lower-extremity peripheral artery disease: A systematic review and meta-analysis.Vasc Med. 2022 Apr;27(2):158-170. doi: 10.1177/1358863X211034577. Epub 2021 Sep 28. Vasc Med. 2022. PMID: 34579581 Free PMC article.
References
-
- Hirsch AT, Criqui MH, Treat-Jacobson D, et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA. 2001 Sep 19;286(11):1317–1324. - PubMed
-
- Fowkes FG, Housley E, Cawood EH, Macintyre CC, Ruckley CV, Prescott RJ. Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. Int J Epidemiol. 1991 Jun;20(2):384–392. - PubMed
-
- Newman AB, Siscovick DS, Manolio TA, et al. Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Cardiovascular Heart Study (CHS) Collaborative Research Group. Circulation. 1993 Sep;88(3):837–845. - PubMed
-
- Criqui MH, Denenberg JO, Langer RD, Fronek A. The epidemiology of peripheral arterial disease: importance of identifying the population at risk. Vasc Med. 1997;2(3):221–226. - PubMed
-
- Kannel WB, Shurtleff D. The Framingham Study. Cigarettes and the development of intermittent claudication. Geriatrics. 1973 Feb;28(2):61–68. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources